Last ¥684.00 JPY
Change Today -12.00 / -1.72%
Volume 2.2M
4118 On Other Exchanges
Symbol
Exchange
Munich
Tokyo
OTC US
As of 1:31 AM 05/22/13 All times are local (Market data is delayed by at least 15 minutes).

kaneka corp (4118) Snapshot

Open
¥700.00
Previous Close
¥696.00
Day High
¥710.00
Day Low
¥680.00
52 Week High
05/22/13 - ¥710.00
52 Week Low
10/1/12 - ¥370.00
Market Cap
239.4B
Average Volume 10 Days
2.0M
EPS TTM
¥27.68
Shares Outstanding
350.0M
EX-Date
09/26/13
P/E TM
24.7x
Dividend
¥16.00
Dividend Yield
2.34%
Current Stock Chart for KANEKA CORP (4118)

Related News

No related news articles were found.

kaneka corp (4118) Related Businessweek News

No Related Businessweek News Found

kaneka corp (4118) Details

Kaneka Corporation, together with its subsidiaries, manufactures and sells chemicals, functional plastics, expandable plastics and products, foodstuffs products, life science products, electronic products, and synthetic fibers. The company’s chemical products include polyvinyl chloride (PVC), caustic soda, hydrochloric acid, flexible and rigid PVC compounds, paste PVC, chlorinated PVC, dispersion PVC, and PVC pipes; and functional plastic products comprise modifiers, liquid polymers, weather-resistant acrylic films, and engineering plastic compounds. Its expandable plastics and products consist of polypropylene and polyethylene foam, expandable polystyrene, and extruded polystyrene foam boards; and foodstuffs products, such as margarine and shortening, confectionery fats, cacao butter substitute, bakery yeast, creams, margarine crystallized, and spices. The company’s life science products include Coenzyme Q10, a functional foodstuff for use in various food materials, including supplements; QH for regenerative coenzyme Q10; Glavonoid, a food product ingredient to maintain health among middle-aged and older people; AMMPA, an intermediate for anti-hypertensive captopril; Glutathione for hepatic medicine; Catheters for the treatment of inside blood vessels; intermediates for antibiotics; Liposorber LDL-cholesterol adsorption system; Selesorb, a specific adsorption column for SLE; and Lixell, an adsorption column for dialysis-related amyloidosis. Its electronic products comprise polyimide and transparent films, bonded magnets, solar modules, optical materials, thermal-conductive graphite sheets, and wooden house construction systems; and synthetic fibers consist of modacrylic fibers, as well as the ULTIMA, a protein fiber made from collagen that is similar to true human hair in texture and function. The company operates in Japan, Asia, North America, Europe, and internationally. Kaneka Corporation was founded in 1949 and is headquartered in Osaka, Japan.

Founded in 1949

kaneka corp (4118) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

kaneka corp (4118) Key Developments

Kaneka Corporation Reports Consolidated Earnings Results for the Year Ended March 31, 2013; Provides Earnings Guidance for the First Half of Fiscal 2013 and Full Year Ending March 31, 2014

Kaneka Corporation reported consolidated earnings results for the year ended March 31, 2013. For the period, the company reported net sales of JPY 476,462 million compared to JPY 469,289 million a year ago. Operating income was JPY 15,809 million compared to 13,151 million a year ago. Income before income taxes and minority interests was JPY 14,930 million compared to JPY 11,352 million a year ago. Net income was JPY 9,325 million or JPY 27.65 per fully diluted share compared to JPY 5,402 million or JPY 15.95 per fully diluted share a year ago. Net cash provided by operating activities was JPY 32,775 million compared to JPY 15,842 million a year ago. Purchase of property, plant and equipment was JPY 31,782 million compared to JPY 30,643 million a year ago. Purchase of intangible assets was JPY 2,158 million compared to JPY 1,488 million a year ago. Return on equity was 1.5% compared to 3.4% a year ago. For the first half of fiscal 2014, on consolidated basis, the company expects net sales of JPY 240,000 million, operating income of JPY 12,000 million, net income of JPY 6,000 million or JPY 17.81 per share For the year ending March 31, 2014, on consolidated basis, the company expects net sales of JPY 530,000 million, operating income of JPY 30,000 million, net income of JPY 15,000 million or JPY 44.52 per share a year ago.

Kaneka Corporation to Report Fiscal Year 2013 Results on May 10, 2013

Kaneka Corporation announced that they will report fiscal year 2013 results on May 10, 2013

Kaneka Corporation Presents at Daiwa Investment Conference Tokyo 2013, Mar-04-2013

Kaneka Corporation Presents at Daiwa Investment Conference Tokyo 2013, Mar-04-2013 . Venue: The Prince Park Tower Tokyo, Tokyo, Japan.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4118:JP ¥684.00 JPY -12.00

4118 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Metabolix Inc $1.87 USD -0.08
Mitsui Chemicals Inc ¥303.00 JPY +15.00
Toyota Tsusho Corp ¥3,155 JPY +166.00
View Industry Companies
 

Industry Analysis

4118

Industry Average

Valuation 4118 Industry Range
Price/Earnings 23.2x
Price/Sales 0.5x
Price/Book 0.8x
Price/Cash Flow 24.1x
TEV/Sales 0.2x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KANEKA CORP, please visit www.kaneka.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.